Determinants of adherence to obesity medication: a narrative review
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet , 2021;397(10278):971984
What to Expect With Once-Weekly Tirzepatide at PlexusDx Most patients begin tirzepatide at 2.5 mg weekly and follow a four-week dose-escalation schedule: 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg if needed and tolerated
Zheng YJ, Soegiharto C, Au HCT, Valentino K, Le GH, Wong S, et al